Neurovascular Surgery

Blood vessels that are damaged, injured, or deformed can cause bleeding or circulation difficulties, which can lead to strokes, headaches, and other symptoms. Neurovascular surgery treats abnormalities with the blood arteries of the brain, spine, and spinal cord using open or minimally invasive surgical procedures. The subject of neurovascular surgery is becoming increasingly complicated and technological, embracing classic surgical approaches as well as endovascular and neurointerventional techniques. Clinicians in the Neurovascular programme specialise in the treatment of all vascular disorders of the brain and spinal cord using a variety of therapeutic strategies such as surgery, endovascular interventional treatments, stereotactic radiation, and rehabilitation.

•    Aneurysms and Subrachnoid Hemorrhage Pathophysiology
•    Arteriovenous Malformations
•    Cerebral Ischemia and Revascularization
•    Spontaneous Intracerebral Hemorrhages
•    Endarterectomy
•    Endovascular Neurosurgery
•    Open Neurovascular Surgery
•    Hybrid Surgery & Advanced Technology
•    Cerebrovascular Surgery
•    Ischemic Stroke and Vascular Insufficiency
•    Cerebral and Spinal Aneurysms
•    Cerebral and Spinal Arteriovenous Fistulae and Malformations
•    Vascular Tumors
•    Revascularization techniques
•    Vascular Stereotactic Radiosurgery

Market Analysis : The market for neurovascular devices and interventional neurology is predicted to increase at an annual rate of 8.6% from USD 2.5 billion in 2021 to USD 3.8 billion in 2026. The market for neurovascular devices is likely to be driven by the rising frequency of neurological illnesses, technical developments, and the growing desire for minimally invasive operations. Interventional neurology devices are used to diagnose and treat brain and central nervous system vascular disorders. Interventional neurology entails a variety of procedures. From 2021 to 2030, the Neurovascular Devices Market is expected to develop at a compound annual growth rate (CAGR) of 5.7 percent, reaching US$ 4.52 billion.

Alzheimer's Disease Conferences Parkinson Disease Conferences CNS Conferences Neurology Conferences Neurology Conferences 2022 Neurology Conferences 2022 Asia Dementia Conferences Neurological Disorders Conferences Neurodegenerative Disorders Conferences Psychiatry Conferences Child Psychology Conferences Neurology Conferences 2022 USA Spinal Disorders Conferences Neurology Conferences 2022 Neurosurgery Conferences